Use of weak opioids and mixed opioid agonists/antagonists for treatment of urinary incontinence
US7008939B2 · kind B2 · utility
3Cited by
5References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 30, 2003 |
| Grant date | Mar 7, 2006 |
| Priority date | — |
| Expiry date | May 30, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition for the treatment of an increased urge to urinate or urinary incontinence, comprising an effective amount of at least a compound selected from the group consisting of codeine, dihydrocodeine, dextropropoxyphene, meptazinol and tilidine. Also disclosed are methods of treatment using the pharmaceutical compositions and preferred dosages for the treatment methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.